Hemas Holdings PLC (HHL)
|
|
- Lydia Sanders
- 6 years ago
- Views:
Transcription
1 4-Jan-16 4-Feb-16 4-Mar-16 4-Apr-16 4-May-16 4-Jun-16 4-Jul-16 4-Aug-16 4-Sep-16 Price (LKR) 4-Jan-16 4-Feb-16 4-Mar-16 4-Apr-16 4-May-16 4-Jun-16 4-Jul-16 4-Aug-16 4-Sep-16 Price (LKR) Volume (') Hemas Holdings PLC (HHL) Earnings Review BUY Rs.1.7 August 216 CASE FOR INVESTMENT Strong brand image: HHL is one of the strongest conglomerates in Sri Lanka engages in fastest growing sectors such as FMCG, healthcare, transportation and leisure. Market leader in distribution of pharmaceuticals: Hemas Holdings own 18% market share in the pharmaceutical market. Increase in occupancies at Hemas Hospital Chain: Increase in number of patients will improve the profitability, while there is interest to enter Bangladesh healthcare sector. Related investments: Acquiring one of the oldest pharmaceutical companies in Sri Lanka, J. L Morison Son & Jones (Ceylon) PLC will further reinforce the pharmaceutical and FMCG segments of Hemas Holdings. Business Expansions: Enhanced FMCG operations in Bangladesh would enable to strengthen the profitability and mitigate the external risks on business. Portfolio of strong and popular consumer brands: Hemas owns popular household brands such as baby Cheramy, Clogard, Velvet, Kumarika, Pro Sport, Gold etc. in Sri Lanka as well as in more than 1 countries in the world. Managing international hotel brands: The partnership with minor Hotel Group which enabled Serendib Leisure to be the sole Sri Lankan Hotel chain to manage the international hotel brands AVANI and Anantara will positively impact the segment s performance. Increase in tourist arrivals: This is a key performance driver for the transportation and leisure segments. Depreciation in domestic currency: This affects favourably to the export turnover and the leisure segments A Member of the Colombo Stock Exchange Key Data Foreign Broker-Dealer of Maybank Kim Eng Securities USA Inc. Sector Industrial CSE ticker HHL.N Bloomberg ticker HEMS SL Equity Shares in issue 573mn Public holding 35.4% 52wk High - Low LKR Annual Volume 33.5mn Current MPS LKR 1.7 Market Cap LKR 57.7bn Market Cap USD.4bn Major Shareholders 3 th Jun 216 A Z Holdings (Pvt) Ltd 15.85% Saraz Investments (Pvt) Ltd 15.9% Blueberry Investments (Pvt) Ltd 14.98% Amagroup (Pvt) Limited 14.98% HSBC Intl Nominees Ltd- JPMLU-Franklin Templeton 9.67% Investment Funds Top 2 shareholders 87.48% Foreign ownership* 28.97% *As at 5 th September 216 7, 6,8 6, 6, 6, 6, 5,8 5, 5, 5, Relative Share Performance Some of the well-known Hemas FMCG brands in Sri Lanka ASI HHL Price Volume Graph , 2, 1, 1, - HHL Page 1
2 Financial Summary Investor Guide FY17E FY18E Revenue (LKR mn) 27,259 32,497 37,977 44,76 53,566 4% 19% 17% 18% 2 EBIT (LKR mn) 3,484 3,371 3,961 4,336 5,296 43% -3% 17% 9% 22% PAT-E (LKR mn) 2,49 1,927 2,653 3,62 4,578 45% -2 38% 36% 26% Gross margin 34% 35% 37% 37% 36% Operating margin 13% Net margin 9% 7% 8% 8% 9% ROE 18% 14% 13% 16% 18% ROA 8% 6% 7% 9% 11% EPS (LKR) NAV (LKR) PE (x) PBV (x) DPS (LKR) Dividend payout 18% 33% 3 22% 2 Dividend yield 2% 1% 2% 1% 2% Hemas Holdings was established in 1948 as a pharmaceutical company under the name Hemas (Drugs) Ltd, initiated by Sheikh Hasannally Esufally. In 1962 in collaboration with a French multinational, Esufally commenced production of toiletries. With the nationalization of industries and changes in the economic environment Hemas identified the need to diversify the business operations. Accordingly, in 197 HHL entered in to the blooming travel and tourism industry. In 1978 following the open economy concept, Hemas entered into the commodity export business. Expanding the product portfolio HHL launched Clogard toothpaste in 199 which currently enjoys a 35% market share locally. Hemas took major strategic decisions in periods, to divest the group s commodities business and re-enter into the apparel manufacture and the field of Freight and Logistics. In 1993 Hemas Drugs Ltd., was renamed as Hemas Holdings (Pte) Ltd. Hemas travel passed a key milestone in 1994 as Hemas Airline GSA Division being established through GSA for Malaysia Airlines was an important year for HHL as the group acquired controlling interest in Serendib Hotels Ltd., one of the largest leisure sector companies in Sri Lanka. In the same year the group launched Prime Destinations to focus on outbound tour operations and entered a strategic joint venture with Forbes and Walker Group to manage GSA for Emirates. Hemas obtained sole GSA status in Sri Lanka for Emirates Airlines in. Hemas entered into the power sector in in 3, by setting up Heladhanavi as a joint venture with Lakdhanavi Ltd to operate a 1 MW power plant. Several changes in the business took place in 1995 as HHL divested 7 of its apparel business, acquired Nimex paper business and entry into the food sector. In 8, further expanding the business HHL entered into maritime business with Far Shipping Lines Singapore and in the same year Hemas Hospitals in Wattala commenced the operations. Countries do Direct Exports The Maldives Lebanon Bangladesh Belize New Zealand Zambia Malaysia Pakistan Australia The Middle East FMCG brands that export Baby Cheramy Kumarika Clogard Goya Pro Sport In May 213, HHL acquired a controlling stake of J. L Morison Son & Jones (Ceylon). Hemas divested their controlling stake of Hemas power in December 214. HHL Page 2
3 1Q 2Q 3Q 4Q 1QFY17 LKR mn. Quarter Performance 1QFY17 Net earnings up significantly by 68%YoY on increase in revenue Hemas Holdings reported a profit of LKR 696mn with a growth of 68%YoY in June quarter 216 compared to LKR 415mn profit reported in the comparative year. However the profit declined marginally by 2%QoQ compared to the December quarter 215. The significant profit growth was driven by the increase in revenue. Healthcare segment and the FMCG segment were the largest contributors to the group s turnover. HHL has managed to reduce their finance cost by 16%YoY and 29%QoQ to LKR 14mn in the quarter Quarterly profit growth Finance income improved by 89%YoY and 6%QoQ to LKR 25mn in 1QFY17 mainly led by the notable increase in interest income. Profits margins have marginally improved in 1QFY17 compared to 1Q. Net margin improved from 5% to 7%. Gross and Operating margins also have improved from 36% and 8% to 38% and 9% respectively. PAT-E The share of loss of JV and associates increased LKR 35mn in June quarter 216 compared to a loss of LKR 1mn reported in the December quarter 215. It was a significant decline of 28YoY when compared to LKR 2mn profit reported in June quarter 215. Sector Review FMCG Segment FMCG segment reported a hefty PBT growth of 65%YoY in June quarter of 216 to reach LKR 677mn while earnings grew by 63%YoY to LKR 51mn. This segment is the main profit contributor to the group that contributes more than 7 of the total profits. Revenue composition - 1QFY17 The earnings were driven by the volume growth witnessed in major brands in personal wash, personal care, feminine hygiene and home care and in both general trade and modern trade sales channels. 8% 3% 2% 43% The company also expanded their product portfolio by introducing a new range of baby Cheramy diapers, strengthening their position in key product categories. FMCG segment reported revenue of LKR 4.2bn in 1QFY17 with a growth of 1YoY compared to LKR 3.8bn reported in the comparative year. This segment is the second largest revenue contributor to the total turnover. 44% FMCG Healthcare Leisure The Bangladesh operations also continued to perform well contributing a favourable revenue growth during the period. Transportation Other PBT margin has improved notably from 11% to 16% in June quarter of 216. HHL Page 3
4 ' FY12 LKR (') Future outlook FMCG segment may continue the growth momentum in FY17E to record a revenue growth of 21%YoY to reach LKR 17.2bn (FY18E LKR 2.9bn, +22%) underpinned by the overseas revenue, mainly in Bangladesh and strong domestic demand. 2, 1,8 1, PBT growth - FMCG 6 5 The expansion of the product portfolio in baby products, personal wash, personal care, feminine hygiene and home care products may drive the segmental revenue. of FMCG segment PBT in FY17 is estimated to be 33% YoY to reach LKR 2.4bn; backed by the strong revenue growth. FMCG segment may report a net profit growth of 31%YoY to LKR 1.9bn in FY17E driven by strong top line performance and lower income tax rates. 1, 1, 1, The depreciation in rupee would improve export revenue of FMCG segment while the innovative product portfolio would strengthen the growth prospects of the segment. PBT Healthcare Segment Healthcare segment positioned as the market leader in pharmaceutical distribution business is the main revenue contributor to the group. The segment reported revenue of LKR 4.3bn in 1QFY17 (+18%YoY) and a PAT of LKR 241mn (+13%YoY). Revenue growth in healthcare segment was driven by the growing therapeutic segment and the recovering pharmaceutical market. HHL launched their new addition to the pharma portfolio, Jenburket Pharma in May 216 Pakistan Sri Lanka Bangladesh Healthcare expenditure as a % of GDP India Nepal However, hospitals showed mixed results during the quarter as a result of the introduction of VAT for healthcare services. The introduction and subsequent removal of VAT created market confusion among patients and healthcare providers. The Rx Pharma also continued to perform well in the quarter backed by new product launches. Over the counter and consumer segments also have contributed positively to the overall segmental performance. Vietnam Source -: World Bank PBT margin remained unchanged at 8%. Population - 55 years and over Future outlook Healthcare segment net profit in FY17 is estimates to grow at 11% YoY to reach LKR 1.3bn. 4, 3, 3, 2, Revenue is expected improve by 18%YoY to LKR 18.9bn in FY 17E (FY18E LKR 22.6bn, +19%YoY) underpinned by increasing volume. 2, 1, Sri Lanka is one of the fastest growing ageing population countries where approximately 12.4% of the population was above the age of 6 years, according to central bank data release at end-215. This is likely to double in the future, and the public sector alone has insufficient capacity to handle the growth. 1, The private sector accounted for only 27% of the countries hospitals and 7% of bed capacity by end of 214. This will have a clear growth potential of expansion in private healthcare sector with the growing ageing population. Source -: CBSL HHL Page 4
5 FY12 LKR (') USD Mn. FY12 LKR (') Furthermore, the increase in per capita income would improve consumer spending on Private healthcare services. PBT growrh- Healthcare Hemas Hospitals have launched three new laboratories in Akuressa, Tangalle and Moratuwa in, which will continue to make revenue in coming years. Moreover the hospital expanded bed capacity in adding 27 new beds to the existing capacity. This capacity expansion project is expected to be completed in FY17E including the centre of Excellence in Orthopaedics and Gastroenterology. The investments made in 3-bedded High Dependency Unit and a laser lithotripsy machine to build the surgical procedure capability in Urology will continue to be productive in forthcoming years. 1,8 1, 1, 1, 1, Furthermore, Hamas Hospitals also have signed a Memorandum of Understanding with the government-owned National Insurance Trust Fund in to be the preferred hospital for its members. PBT Newly launched Jenburket Pharma product range also will contribute positively to the segmental earnings. Earnings from tourism Hence, considering all the potentials we believe that the segment may continue its growth momentum in the forthcoming years. 3, 3, 2, Leisure Segment 2, The segment reported a net loss of LKR 33mn for the June quarter 216 compared to a profit of LKR 45mn reported in the comparative year led by the losses incurred by the joint ventures and associates. 1, 1, Revenue was LKR 776mn with a growth of 8%YoY in 1QFY17 compared to LKR 717mn recorded in 1Q. - Serendib Hotels, a subsidiary of HHL posted a marginal revenue growth of 5%YoY to LKR 311mn during the quarter with traditional market performing. Nonetheless the markets were performed merely below the expectations during the quarter. However, occupancies at AVANI Bentota and Club Hotel Dolphin declined during the quarter amid the usual low season for the leisure industry which slowed down the revenue compared to the comparative year performance. Free fall of the Euro owing to BREXIT affected for the segmental results as it adversely affected the traditional earnings from German, UK and France markets. PBT growth-leisure 3 The Travel and Aviation segment showed mixed results in June 216, and as a result of it the segment reported a revenue growth of a marginal 4%YoY Future outlook The leisure segment is expected to report revenue growth 16%YoY to LKR 3.9bn in FY17E and LKR 4.6bn, +17%YoY revenue in FY18E. The segment may report a PAT of LKR 83mn in FY17E The first international 5 star brand hotel namely Anantara, Peace Haven, Tangalle commenced its operations on 1st December 215 and the second hotel Anantara PBT HHL Page 5
6 FY12 FY17E LKR () E Passenger FY12 LKR (') Kalutara, is scheduled to open by September 216. This may improve the top line and profitability of the segment. PBT growth- Transportation The government s continuous focus on improving the tourism sector will eventually impact favourably to the leisure industry. Removal of Tourism Development Levy (TDL) from the budget 216 will favourably affect to the segments profitability Transportation 1 The segment reported revenue of LKR 334mn with a growth of 63%YoY in 2Q. Revenue growth of 15%YoY to LKR 829mn recorded in 1H underpinned by the strong performance in logistics business. PBT -1 The growth of the logistics business was mainly driven by new projects, warehouses operating with full capacity and haulage business growing with the car carrier operations. In April 216, Hemas Maritime was appointed the exclusive shipping line agent of Evergreen Lines, which will enable the company to positioned itself strongly in the logistics and maritime sector. The domestic logistics operations coupled with warehouse operations witnessed strong performance levels underpinned by new customers and higher level of container handling activity during the quarter. 9% 8% 7% 6% 5% Annual growth in global traffic passenger demand % 5.7% 5.3% 5.2% 7.4% 6.2% Future Outlook 4% 3% Transportation segment revenue in FY17 is estimated to be LKR 2.1bn (+19%YoY) and LKR 2.4bn in FY18E (+18%YoY). 2% 1% Transportation segment may post a PAT of LKR 476mn with a growth of 19%YoY in FY17E. The company s Airline GSAs such as Emirates and Maldivian (Passenger & Cargo) and Ukraine International Airline, Druk Air and Alitalia Airline (passenger only) may maintain the strong growth prospects in forthcoming years. Source -: Statista/IATA Malaysian Airlines is recovering from the lost grounds after the tragic incidents happened to MH37 and MH17. However, the airline provided significant discounts and offers to attract passengers which resulted to increase in the traffic passenger demand. This is positive to HHL for the growth of the segmental top line. Further Emirates have become the world s best airline in 216 from the position of 5 in 215. The recognition coupled with substantial promotions has given the opportunity to experience heavy number of passengers using the airline. 2,3 1,8 1,3 8 Transportation sector revenue 55% 45% 35% 25% 15% The Government decision to remove restrictions on Global Logistics Companies, which have the scale, capacity, capital and knowledge to expand services using Sri Lanka as the hub where they should be able to invest, acquire and operate within a reasonable tax regime would be positively impacted to the logistic business of the company. 3 - Revenue 5% -5% However the increase in over flying charges of commercial planes by 2 may impact the GSA travel business. The government further plans to increase charge. HHL Page 6
7 FY17E LKR FY17E LKR Bn USD Bn. Passenger and cargo air traffic are estimated to increase the revenue passenger kilometres by about 6.2% and freight tonnes kilometres by around 1.9% by end of 216 according to IATA. This may help to improve the travel business of transportation segment. Recovering global economy may strengthen tourist arrivals which will boost the segmental turnover. However, decision of BREXIT which resulted to the weaken euro and GBP may merely affect the European tourist arrivals. The strategic investment on cargo GSA for Maldivian Airlines in Thailand will benefit the segments turnover in the further while easing the macro economic challenges faced by Hemas with in Sri Lanka. Future outlook of Hemas Holdings The group PAT in FY17 is estimated to be LKR 3.6bn; up by 36%YoY (LKR 4.7bn, +29% in FY18E) on increase in revenue and decrease in income tax expenses. 3 1 Worldwide revenue in passenger air traffic Source -: Statista/IATA 511 The government has reduced the corporate tax rate from 28% to 17.5%. Subsequently the effective tax rate also would come down as the company can benefit from the reduction. Revenue is estimated to increase by 18%YoY to LKR 44.7bn in FY17E, and +2 in FY18E to reach LKR 53.5bn. Net margin may remain unchanged in FY17E at 8% but it is estimated to improve in FY18E to 9%. Further, Hemas would benefit from the rupee depreciation on the export turnover in the FMCG business and the hospitality business Profit margins with turnover 4 35% 3 25% 2 15% 1 5% The group is vulnerable to forex losses on dollar borrowings. However, use of financial derivatives such as forward currency contracts to hedge foreign currencies mitigate this risk. Turnover Operating margin Gross margin Net margin Moreover, there are some term loans which are payable at an interest rate of EURIBOR. The quantitative easing programme of ECB will help HHL to reduce their finance costs. Trailing debt to equity ratio is at 26% while trailing return on equity ratio is at 13Further, trailing return on assets ratio stand at 7%. The trailing asset value stand at LKR per share. The increasing profitability of the company may translate to a CAGR of 14% in next 3-years. We believe that the company may maintain the same dividend level in FY17E at LKR 1.4 per share which translates to a dividend pay-out of 22% EPS, DPS vs. Payout 4 35% 3 25% 2 15% 1 5%. EPS DPS Payout HHL Page 7
8 Valuation Based on weighted average price calculated using the discounted cash flow method and the sum of the part method we have arrived to an attractive price valuation of LKR per share with an upside of 16%. The counter is currently trading at a PE of 19.1x and a PBV of 2.4x which are at a premium to the sector multiples. However the company s ROE of 13% is relatively attractive when compared to peers and the overall market. Considering the positive earnings prospects of each segment and attractive multiples we believe that the counter will perform well in the future. The strategic decisions of the company to make more investments in wellness, leisure and mobility segments will boost the profitability. Hence, we recommend BUY. 52wk Low Price 72. Historical PBV Price Peer PE Price Market Price 52wk High Price Historical PE Price Weighted Average Price Stock Market Performance 3M 6M 12M ASI 8% -1 HHL.N 1 24% 12% Relative Comparison PE PBV ROE ASI % Industrial Sector % HHL.N % HHL Page 8
9 Quarterly Earnings LKR Millions Jun-15 Sep-15 Dec-15 Mar-16 Jun-16 QoQ% YoY% Revenue 8,815 9,596 9,875 9,69 9,886 2% 12% Cost of Sales (5,638) (6,13) (6,237) (5,951) (6,123) 3% 9% Gross Profit 3,177 3,493 3,638 3,739 3,763 1% 18% Other Operating Income % -16% Selling and Distribution Expenses (1,52) (1,16) (919) (892) (1,19) 33% 13% Administrative Expenses (1,542) (1,55) (1,586) (1,81) (1,689) -6% 1 Share of results of Joint ventures & Associates 2 (54) (44) (1) (35) 253% -279% Operating Profit ,173 1, % 35% Finance Cost (123) (117) (126) (146) (14) -29% -16% Finance Income % 89% Profit Before Tax ,226 1,224 1,1-17% 53% Income Tax Expenses (23) (294) (37) (334) (39) -7% 34% Profit for the period % 63% Attributable to: Equity Holders of the Parent % 68% Non-Controlling Interests % -69% Gross Margin 36% 36% 37% 39% 38% - - Operating Margin 8% 1 12% 12% 9% - - Net Margin 5% 7% 9% 9% 7% - - Total Assets 39,136 4,299 4,395 42,327 43,311 2% 11% Total Equity - Equity Holders 2,131 2,356 2,437 21,992 22,719 3% 13% Total Liabilities 16,816 17,726 17,73 17,674 17,976 2% 7% HHL Page 9
10 APPENDIX 1 Disclaimer This information and opinion contained in this report have been complied by our research department from sources believed by it to be reliable and in good faith, but no representation or warranty, express or implied is made as to their accuracy, completeness or correctness. All opinions and estimates contained in the document constitute the department s judgment as of the date of this document and are subject to change without notice and are provided in good faith but without legal responsibility. This report is not, and should not be construed as, an offer to sell or a solicitation of an offer to buy any securities. Capital Trust Securities (Pvt) Ltd. (the company) or persons connected with it may from time to time have an investment banking or other relationship, including but not limited to, the participation or investment in commercial banking transactions (including loans) with some or all of the issuers mentioned therein, either for their own account or the account of their customers. Persons connected with the company may provide or have provided corporate finance and other services to the issuer of the securities mentioned herein, including the issuance of options on securities mentioned herein or any related investment and may make a purchase and/or sale, or offer to make a purchase and/or sale of the securities or any related investment from time to time in the open market or otherwise, in each case either as principal or agent. This report may contain forward looking statements which are often but not always identified by the use of words such as anticipate, believe, estimate, intend, plan, expect, forecast, predict and project and statements that an event or result may, will, can, should, could or might occur or be achieved and other similar expressions. Such forward looking statements are based on assumptions made and information currently available to us and are subject to certain risks and uncertainties that could cause the actual results to differ materially from those expressed in any forward looking statements. Readers are cautioned not to place undue relevance on these forward looking statements. Capital Trust Securities expressly disclaims any obligation to update or revise any such forward looking statements to reflect new information, events or circumstances after the date of this publication or to reflect the occurrence of unanticipated events. Exchange rate fluctuations may affect the return to investors. Neither the company nor any of its affiliates, nor any other person, accepts any liability whatsoever for any direct or consequential loss arising from any use of this report or the information contained therein. Capita TRUST Securities (Pvt) Ltd, their respective affiliate companies, associates, directors and/or employees may have investments in securities or derivatives of securities of companies mentioned in this report, and may make investment decisions that are inconsistent with the views expressed in this report., it s directors, officers, consultants, employees, associates or business partner, will not be responsible, for any claims damages, compensation, suits, damages, loss, costs, charges, expenses, outgoing or payments including attorney s fees which recipients of the reports suffers or incurs directly or indirectly arising out actions taken as a result of this report. HHL Page 1
11 TELEPHONE : (11) HOTLINE : (11) FAX : (11) E MAIL : inquiries@capitaltrust.lk TRADING DIVISION BOARD OF DIRECTORS Tushan Wickramasinghe (11) Moksevi Prelis (Chairman) Dakshana Gooneratne (11) Tushan Wickramasinghe (Managing Director/CEO) Lawrence David (11) Methmal Senivirathne (CFO) M J M Husni (11) Sandesh Jayakody (11) Nilantha Perera (11) Saliya Gamagedera (11) Asanka Perera (11) Shanmugassharma Rakesh (11) Rasika Vidanalage (11) Thilina Yahampatharachchi (11) Sajee Perera (11) Gayan Vithanage (11) Anushan Kandasamy (11) Shehan Mendis (11) Chamila Fernando (11) Dilshard Hameed (11) Danushka Arambegedra (11) Laxman Ratnayake (11) KANDY BRANCH Arjuna Wilbawa (81) Dasantha Herath (81) Mohomed Faizan (81) FAX (81)-2215 KURUNEGALA BRANCH Dammika Senarathne (37) Indunil Pradeep (37) FAX (37) NEGOMBO BRANCH Sanjeewa Perera (31) Narada Abeysinghe (31) FAX (31) MATARA BRANCH Venura Gamage (41) Jagath Rathnayake (41) Tharanga Wijeweera (41) FAX (41) MORATUWA BRANCH CAPITAL TRUST RESEARCH (PVT) LTD Suneth Fernando (11) Charitha Gunasekere (11) Bhanuka De Silva (11) Melani Nawaratne (11) Asoka Dharmatilaka (11) Ruvini Kaushalya (11) FAX (11) CUSTOMER SERVICE DIVISION CAPITAL TRUST CREDIT (PVT) LIMITED Prashani Perera (11) (11) ACCOUNTS DIVISION CAPITAL TRUST FINANCIAL (PVT) LIMITED Methmal Senivirathne (11) Anushan Kandasamy (11) Ranjini Jayawardena (11) Subani Wimalarathne (11) Kumari De Alwis (11) DOCUMENTATION DIVISION N.M.A Navaratne (11)
Orient Finance PLC - IPO
Orient Finance PLC Initial Public Offering of Ordinary Shares 71.5 Mn Voting Shares Sector: Banking, Finance & Rs.15.00 January 2016 About the Company Issue price (Rs) 15.00 Orient Finance PLC is a subsidiary
More informationDialog Axiata PLC CASE FOR INVESTMENT. Earnings Review BUY Rs May 2016
May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 LKR Dialog Axiata PLC Earnings Review BUY Rs.11.40 May 2016 CASE FOR INVESTMENT Being the market
More informationThe share is undervalued compared to its; peers, banking sector and the overall market
Seylan Bank PLC Earnings Review: BUY V Rs. 69.80 NV Rs.41.80 July 2014 Company Snapshot Seylan Bank PLC () was incorporated in 1987 as a public listed company. is engaged in commercial banking and provides
More informationACL Cables PLC (ACL) CASE FOR INVESTMENT. Earnings Review BUY Rs December 2015
1-Oct-13 1-Jan-14 1-Apr-14 1-Jul-14 1-Oct-14 1-Jan-15 1-Apr-15 1-Jul-15 1-Oct-15 Price (LKR) 2-Jan-14 2-Apr-14 2-Jul-14 2-Oct-14 2-Jan-15 2-Apr-15 2-Jul-15 2-Oct-15 Axis Title Volume (') ACL Cables PLC
More informationCopper prices are forecasted to decline at a CAGR of 2.7% over the next 5 years (World Bank). This will improve gross profit margins of the company.
Cables PLC Earnings Review - BUY Rs. 63.60 November 2013 INTRODUCTION Cables PLC () was incorporated in 1962 as the first electric cable manufacturing company in Sri Lanka. Group is the largest cable manufacturer
More informationPeople s Leasing Company Ltd IPO
People s Leasing Company Ltd Initial Public Offering of 390 Million Shares Earnings Review SUBSCRIBE SLRs.18.00 October 2011 Background People s Leasing Company Limited (PLCL) is a subsidiary of the state
More information2017 Budget - Highlights The Democratic Socialist Republic of Sri Lanka 70 th Budget Since Independence 10 th November 2016
2017 Budget - Highlights The Democratic Socialist Republic of Sri Lanka 70 th Budget Since Independence 10 th November 2016 2017 Budget at a Glance Government Revenue and Grants for 2017 is projected to
More informationHemas Holdings PLC. Interim Update (Q1 FY 14/15) 23 rd September 2014 Diversified Sector. Valuation. Recommendation: SELL LOLC SEC Valuation: LKR 52
Hemas Holdings PLC Interim Update ( ) 23 rd September 214 Diversified Sector Revenue has gained 19.5% QOQ while profit attributable to shareholders decreased by 1.8% for the amidst the mix performance
More informationINTERIM REPORT Q4-2016/17 EXPLORE. ENGAGE.
Hemas Holdings PLC INTERIM REPORT Q4-2016/17 EXPLORE. ENGAGE. CEO s Review Hemas Holdings PLC (HHL) and its subsidiaries achieved consolidated revenues of Rs.43.4Bn, year-onyear (YoY) growth of 14.3% for
More informationAdani Ports & SEZ Rating: Target price: EPS:
Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT
More informationGillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance
2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings
More informationColgate-Palmolive (India)
Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue
More informationApollo Hospitals Enterprise Ltd.
Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17. Volume No.. I Issue No. 154 Apollo Hospitals Enterprise Ltd. December 19, 2017 BSE Code: 508869 NSE Code: APOLLOHOSP
More informationMargins(%) EBITDA 30.0% 26.3% 25.4% NPM 26.5% 12.5% 18.1%
RESULTS REVIEW Share Data Market Cap Rs. 1,460.7 bn Price Rs. 177.2 BSE Sensex 15,049.86 Reuters NTPC.BO Bloomberg NATP IN Avg. Volume (52 Week) 2.6 mn 52-Week High/Low Rs. 291 / 148.75 Shares Outstanding
More informationITC Ltd. BUY CMP (Rs.) 304 Target (Rs.) 336 Potential Upside(%) 11% Valuation: Investment Rationale. For private circulation only
Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18. Volume No.. I Issue No. 186 ITC Ltd September 21, 2018 BSE Code: 500875 NSE Code: ITC Reuters Code: ITC.NS Bloomberg
More informationHEMAS HOLDINGS PLC INTERIM REPORT Q1-2017/18 ENGAGE. EMPOWER.
HEMAS HOLDINGS PLC INTERIM REPORT Q1-2017/18 ENGAGE. EMPOWER. WWW.HEMAS.COM CEO s Review Hemas Holdings PLC (HHL) and its subsidiaries achieved a consolidated revenue of Rs.11.4Bn; a year-onyear (YoY)
More informationHEMAS HOLDINGS PLC (HHL) Enriching Investment!
10/4/16 11/4/16 12/4/16 1/4/17 2/4/17 3/4/17 4/4/17 5/4/17 6/4/17 7/4/17 8/4/17 9/4/17 INSTITUTIONAL EQUITY RESEARCH HEMAS HOLDINGS PLC (HHL) Enriching Investment! SRI LANKA DIVERSIFIED SECTOR INITIATING
More informationColgate-Palmolive. Q3FY17 Result Update Steep decline in Sales; EBITDA margin contraction continues. Sector: FMCG CMP: ` 879. Recommendation: HOLD
Colgate-Palmolive Q3FY17 Result Update Steep decline in Sales; EBITDA margin contraction continues Sector: FMCG CMP: ` 879 Recommendation: HOLD Market Statistics Current stock price (`) 879 Shares O/S
More informationHEMAS HOLDINGS PLC INTERIM REPORT ENGAGE. EMPOWER.
HEMAS HOLDINGS PLC INTERIM REPORT Q3 Q1-2016/17 2017/18 ENGAGE. EMPOWER. WWW.HEMAS.COM CEO s Review Hemas Holdings PLC (HHL) and its subsidiaries reported a consolidated revenue of Rs.35.6Bn; a year-onyear
More informationCommercial Bank of Ceylon PLC (COMB) Rs
Sri Lanka Equities CORPORATE UPDATE August 2009 John Keells Stock Brokers (Pvt) Ltd. A JKSB Research Publication Yolan Seimon yolan@jkstock.keells.com Commercial Bank of Ceylon PLC (COMB) Rs 145.00 BUY
More informationGillette India. Institutional Equities. 1QFY18 Result Update
1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance
More informationAhluwalia Contracts (India)
May-14 Jul-14 Aug-14 Sep-14 Oct-14 Dec-14 Jan-15 Feb-15 Apr-15 May-15 India Research Infrastructure May 22, 215 QUARTERLY REVIEW Bloomberg: AHLU IN Reuters: AHLU.BO BUY Better performance ahead ACIL posted
More informationBUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%
Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May- Jun-16 Jul-16 Aug-16 Aug-16 Sep-16 Oct-16. Volume No.. I Issue No. 95 Dewan Housing Finance Corporation (DHFL) Nov. 4, 2016 BSE Code: 511072 NSE Code: DHFL
More informationTOP CA CASE STUDY EXAMINATION MAY
Copyright Reserved No. of Pages - 16 TOP CA CASE STUDY EXAMINATION MAY 2014 ADVANCE INFORMATION Hamson s Business Prospects The Hamson Group Hamson Group (HG) is a large scale conglomerate established
More informationAitken Spence Hotel Holdings PLC
LKR Aitken Spence Hotel Holdings PLC Interim Update Q3 FY 14/15 Equity Research Quarterly revenue increased by only 2% compared to corresponding previous quarter while gross margins grew slightly. Other
More informationInstitutional Equities
4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account
More informationKalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256
: price: EPS: How does our one year outlook change? We expect KPP s revenue (standalone) to grow by 21% y-o-y in FY17E backed by an order book of Rs. 91bn (1.7x FY17E book-to-bill). Both Transmission line
More informationLarsen & Toubro Ltd.
Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Volume No.. III Issue No. 163. Larsen & Toubro Ltd. February 26, 2018 BSE Code: 500510 NSE Code: LT Reuters Code:
More informationJamna Auto Industries
2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were
More informationHEMAS HOLDINGS PLC Interim Report - 3rd Quarter 2012/13
HEMAS HOLDINGS PLC Interim Report - 3rd Quarter 2012/13 CEO s Review It is with great pleasure that I present you the results of the third quarter of 2012/13. Your Company has been successful in continuing
More informationFineotex Chemical Ltd
Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to
More informationANALYST CERTIFICATIONS AND REQUIRED DISCLOSURES BEGIN ON PAGE 21
July 2017 FC Research ANALYST CERTIFICATIONS AND REQUIRED DISCLOSURES BEGIN ON PAGE 21 Monetary Policy Review..... 3 Rating Outlook: Moody s... 4 Inflation... 5 M2B & Sector Credit... 7 Reserves & Liquidity...
More informationSIEMENS INDIA LIMITED RESEARCH
RESULTS REVIEW Siemens India Limited Hold Share Data Market Cap Rs. 196.1 bn Price Rs. 581.6 BSE Sensex 14,961.07 Reuters Bloomberg Avg. Volume (52 Week) SIEM.BO SIEM IN 0.2 mn 52-Week High/Low Rs. 1,142.5
More informationAitken Spence Hotel Holdings PLC
LKR Aitken Spence Hotel Holdings PLC Interim Update Q2 FY 15/16 Equity Research Second quarter net revenue remained stagnant compared to corresponding year previous quarter while profit from operations
More informationBloomberg Code: ATA IN
Auto OEM: 3-Wheelers Atul Feb Auto 03, 2015 Ltd India Research Stock Broking Bloomberg Code: ATA IN Stable quarter led by surge in exports volumes (TP revised ) : Operating revenue, EBITDA and PAT grew
More informationCompany Overview. Industry Overview. Financial Performance
Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 Trade Wings Limited CMP: 105.00 January 29, 2016 Stock Details BSE code 509953 BSE ID TRADWIN Face value ( ) 10 No of
More informationITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%
4QFY18 Result Update Institutional Equities ITC 17 May 2018 Reuters: ITC.NS; Bloomberg: ITC IN Tracking Expectations ITC s growth in 4QFY18 was modest and in line with expectations. On the revenue side,
More informationIDBI Bank RESEARCH. EQUITY RESEARCH July 29, 2008
RESULTS REVIEW IDBI Bank Hold Share Data Market Cap Rs. 53.7 bn Price Rs.74.05 BSE Sensex 13,791.54 Reuters IDBI.BO Bloomberg IDBI IN Avg. Volume (52 Week) 2.4 mn 52-Week High/Low 177.7 / 60.6 Shares Outstanding
More informationAitken Spence Hotel Holdings PLC (AHUN)
Sri Lanka Equities CORPORATE UPDATE November 2009 john Keells Stock Brokers (Pvt) ltd. A JKSB Research Publication Jeewanthi Malagala jeewanthi@jkstock.keells.com Aitken Spence Hotel Holdings PLC (AHUN)
More informationHEMAS HOLDINGS PLC INTERIM REPORT Q4-2017/18 ENGAGE. EMPOWER.
HEMAS HOLDINGS PLC INTERIM REPORT Q4-2017/18 ENGAGE. EMPOWER. WWW.HEMAS.COM CEO s Review Hemas Holdings PLC (HHL) reported full year consolidated revenue of Rs.50.9Bn, an increase of 17.2% over last year
More informationVisaka Industries Ltd
Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%
More informationKey estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,
: price: EPS: How does our one year outlook change? We retain our positive stance on TTMT driven by continued strong performance at JLR on both revenues & margins and expected reduction in losses at standalone
More informationHemas Holdings PLC Interim Report-- 2nd 1st Quarter 2014/ /15
Hemas Holdings PLC Interim Report-- 2nd 1st Quarter 2014/15 2014/15 CEO s Review It is a pleasure to present the results of your company for the first half of the financial year 2014/15. The group has
More informationSQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E
Company Update Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E EBITDA Margins recovered by 618 bps QoQ: The company has witnessed many challenges over the year FY17 starting
More informationCummins India Ltd Bloomberg Code: KKC IN
Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn
More informationCMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630
1QFY18 Result Update July 28,2017 CMP* (Rs) 208 Bloomberg Ticker CROMPTON IN Market Cap. (Rs bn) 130.6 Free Float (%) 65.6 Shares O/S (mn) 630 Channel De-stocking Impairs Top-line; Recovery Ahead Crompton
More informationStandalone Quarterly results (YE Mar) 1QFY14 1QFY15 % yoy FY13 FY14 % yoy
India I Equities Healthcare Result Update 15 July 2014 Unichem Laboratories Recovery in sight; Buy Key takeaways Results slightly above our estimates. Unichem Laboratories (Unichem) revenue grew 9.6% yoy,
More informationMCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176
: price: EPS: Tepid volume growth continues 4QFY15 traded volumes in MCX showed a small improvement sequentially whereas declined yoy. FY15 traded Values are at a sever year low. We retain our cautious
More informationHDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%
Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17. Volume No.. I Issue No. 147 HDFC Bank Oct. 31, 2017 BSE Code: 500180 NSE Code: HDFCBANK Reuters Code: HDBK.NS
More informationCommercial Bank of Ceylon Ltd (COMB)
Rs. 146.00 180 160 140 120 100 80 60 40 Price Volume Sri Lanka Equities Corporate Update Commercial Bank of Ceylon Ltd (COMB) COMB PRICE - VOLUME GRAPH Price 01-Apr-03 09-May-03 17-Jun-03 18-Jul-03 21-Aug-03
More informationPEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)
BUY CMP 1189.45 Target Price 1350.00 CUMMINS INDIA LTD Result Update (PARENT BASIS): Q1 FY16 AUGUST 10 th, 2015 ISIN: INE298A01020 Index Details Stock Data Sector Industrial Machinery BSE Code 500480 Face
More informationBUY SIMPLEX INFRASTRUCTURES LTD SYNOPSIS. CMP Target Price FEBRUARY 28 th Result Update (PARENT BASIS): Q3 FY15
BUY CMP 408.40 Target Price 460.00 SIMPLEX INFRASTRUCTURES LIMITED Result Update (PARENT BASIS): Q3 FY15 FEBRUARY 28 th 2015 ISIN: INE059B01024 Index Details Stock Data Sector Construction & Engineering
More informationSimplex Infrastructures
May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve
More informationCentury Plyboards (India)
: price: EPS: How does our one year outlook change? Century Plyboards (India) (CPBI) 2QFY17 revenues grew by 6% yoy driven by 2% yoy growth in plywood products and 11% yoy growth in laminate products.
More informationSymphony Ltd. RESULT UPDATE 31st October 2017
. RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential
More informationThe Company for Cooperative Insurance Insurance TAWUNIYA AB 8010.SE
Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 Recommendation Overweight Current Price (SAR) 82.60 Target Price (SAR) 101.13 Upside/Downside (%) 22.4% As of
More informationCargills (Ceylon) PLC (CARG) 1QFY15 results
Sri Lanka Beverage, Food & Tobacco EQUITY RESEARCH Earnings review note 02 September 2014 Cargills (Ceylon) PLC (CARG) 1QFY15 results Key highlights and outlook Revenue grows, while margins are impacted
More informationPidilite Industries Ltd
Company Update De-stocking as an initial response to GST implementation caused subdued performance; Brighter long term business prospects ahead The company has recorded sales of Rs. 16693 Mn in as against
More informationTimken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy
4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer
More informationTURKEY: RECENT DEVELOPMENTS January March 2018
TURKEY: RECENT DEVELOPMENTS January March 218 3 81 4 698 961 7 34 7 96 9 66 8 98 1 931 1 6 11 2 11 88 11 19 1 883 1 97 12 48 12 112 Per capita GDP tripled while nominal GDP quadrupled in last 1 years 237
More informationTURKEY: RECENT DEVELOPMENTS January June 2018
TURKEY: RECENT DEVELOPMENTS January June 218 3 81 4 698 961 7 34 7 96 9 66 8 98 1 931 1 6 11 2 11 88 11 19 1 883 1 97 12 48 12 112 Per capita GDP tripled while nominal GDP quadrupled in last 1 years 237
More informationTURKEY: RECENT DEVELOPMENTS January September 2018
TURKEY: RECENT DEVELOPMENTS January September 218 3 81 4 698 961 7 34 7 96 9 66 8 98 1 931 1 6 11 11 88 11 19 1 883 1 97 12 48 12 112 Per capita GDP tripled while nominal GDP quadrupled in last 1 years
More informationLARGE CAP & 1,970 BSE
Batlivala & Karani RESULT UPDATE LARGE CAP Share Data Reuters code DIVI.BO Bloomberg code DIVI IN Market cap. (US$ mn) 4,97 6M avg. daily turnover (US$ mn) 4.7 Issued shares (mn) 133 Target price (Rs)
More informationCMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630
4QFY17 Result Update June 02,2017 Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630 Decent Performance to Continue; Maintain Crompton Greaves Consumer Electricals (CGCEL) has delivered a
More informationITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.
: price: EPS: Relative better visibility despite the smoke, Maintain BUY ITC reported revenues of Rs.~87.2bn (+13% y-o-y), operating profits of Rs.32.8bn (+15% y-o-y) and PAT of Rs.~23.8bn (+16% y-o-y).
More informationKey estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,
: price: EPS: How does our one year outlook change? We retain our negative stance on the stock. We expect s revenue to de-grow by 9% y-o-y on the back of muted execution (client side and clearance delays)
More informationGoodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials
1QCY212 Result Update Tyres June 6, 212 Goodyear India Performance Highlights Y/E December (` cr) 1QCY212 1QCY211 % chg (yoy) 4QCY211 % chg (qoq) Net sales 331 336 (1.6) 395 (16.2) EBITDA 2 24 (18.6) 34
More informationAitken Spence Hotel Holdings PLC (AHUN)
Sri Lanka Equities Corporate Update July 2010 John Keells Stock Brokers (Pvt) Ltd. A JKSB Research Publication Jeewanthi Malagala jeewanthi@jkstock.keells.com Aitken Spence Hotel Holdings PLC (AHUN) Rs.420.00
More informationCMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7
2QFY18 Result Update November 23, 2017 Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7 High Order Book Provides Revenue Visibility (PMPL) has delivered a healthy performance in 2QFY18.
More informationMaruti Suzuki India Ltd.
Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18. Volume No.. I Issue No. 192 Maruti Suzuki India Ltd. November 19, 2018 BSE Code: 532500 NSE Code: MARUTI Reuters
More informationAxis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018
Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Volume No.. III Issue No. 188. Axis Bank Ltd. October 08, 2018 BSE Code: 532215 NSE Code: AXISBANK Reuters Code:
More informationMaruti Suzuki (RHS) BUY. Operationally In Line; Reiterate Buy. Automobiles October 31, 2014 RESULT REVIEW. Outlook & Valuation.
Oct13 Dec13 Jan14 Feb14 Apr14 May14 Jun14 Aug14 Sep14 Oct14 India Research Automobiles RESULT REVIEW Bloomberg: MSIL IN Reuters: MRTI.BO BUY Operationally In Line; Reiterate Buy India s (MSIL) Revenue/EBIDTA/PAT
More informationMaruti Suzuki India Ltd.
Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17. Volume No.. II Issue No. 132 Maruti Suzuki India Ltd. August 4, 2017 BSE Code: 532500 NSE Code: MARUTI Reuters
More informationBUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues
Q3FY17 RESULT UPDATE Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 GEOJIT Research Nov-16 Dec-16 Jan-17 Feb-17 RETAIL EQUITY RESEARCH ICICI Bank Ltd Banking BSE CODE:532174 NSE CODE: ICICIBANK
More informationQ4 EARNINGS REPORT Welspun India 25 Apr 17
Dec-11 Apr-12 Aug-12 Dec-12 Apr-13 Aug-13 Dec-13 Apr-14 Aug-14 Dec-14 Apr-15 Aug-15 Dec-15 Apr-16 Aug-16 Dec-16 Q4 EARNINGS REPORT Welspun India 25 Apr 17 CMP (Rs) 94 TP (Rs) 112 Maintain Outperformer
More informationMuthoot Finance. Institutional Equities. 2QFY18 Result Update BUY
2QFY18 Result Update Institutional Equities Muthoot Finance 10 November 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Really Glitters Strong profitability numbers of Muthoot Finance (MFL)
More informationHEMAS HOLDINGS PLC Interim Report - 2nd Quarter 2012/13
HEMAS HOLDINGS PLC Interim Report - 2nd Quarter 2012/13 CEO s Review It is with great pleasure that I present to you the results of the second quarter of 2012/13. The financial statements are prepared
More informationKey estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,
: price: EPS: How does our one year outlook change? We maintain our negative stance on SKF India due to the absence of significant growth momentum drivers over the medium term. While railways could be
More informationDr Reddy s Laboratories
: price: EPS: How does our one year outlook change? We maintain rating on DRRD post the company s 3QFY16 results Revenue growth for the quarter was muted (3% yoy) due to disappointing performances in Russia
More informationCentury Plyboards (India)
: price: EPS: How does our one year outlook change? We continue to maintain our positive stance on Century Plyboards (CPBI) as it is one of the leading players in the organized plywood market and third
More informationKENANGA INVESTMENT CORPORATION LTD
Rate (%) Yield (%) KENANGA INVESTMENT CORPORATION LTD Rate (%) LKR/USD Rate(%) (%) Yield(%) Change(%) Sri Lankan Economic Update Weekly 14 th Aug 215 COUNTRY RATING: FITCH: BB-, S&P: B+, MOODY S: B1 Economic
More informationInvestor Presentation
Investor Presentation November 2014 Disclaimer The information in this presentation has been prepared by CEAT Limited (the Company ) and has not been independently verified. No representation or warranty
More informationCompany Overview. Financial Performance
Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 CMP: 32.30 February 11, 2016 Stock Details BSE code 526558 BSE ID JAMEHOT Face value ( ) 10 No of shares (m) 8.0 52 week
More informationQuarterly results (YE Mar) 2QFY14 2QFY15 % yoy H1FY14 H1FY15 % yoy
India I Equities Healthcare Result Update 3 November 2014 Granules India Strong performance, margin improvement to sustain; Buy Rating: Buy Target Price: `1,185 Share Price: `807 Key takeaways Strong quarter.
More informationTrident Ltd. Buy & Add on dips
Trident Ltd. Buy & Add on dips 33,351.8 38,689.6 37,553.3 36,656.6 46,944.2 18-Apr-17 18-May-17 18-Jun-17 18-Jul-17 18-Aug-17 18-Sep-17 18-Oct-17 18-Nov-17 18-Dec-17 18-Jan-18 18-Feb-18 18-Mar-18 Trident
More informationTune Ins Holdings Berhad. Financial Results March 2015 Analyst Presentation May 2015
Tune Ins Holdings Berhad Financial Results March 2015 Analyst Presentation May 2015 1 Agenda Page Executive Summary 3-7 Key highlights 1Q2015 financial highlights Update on Strategies Snapshot of Indonesia
More informationSri Lankan Banking Sector
Contents Executive Summary 03 Banking Sector Growth The Economy 05 Credit Growth 06 Loans 07 Deposits 09 Borrowings 10 Risks in the Banking System Credit Risk 11 Interest Rate Risk 12 Exchange Rate Risk
More informationSwaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE
2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above
More informationCMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143
1QFY18 Result Update July 25, 2017 Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143 Limited DPD Impact; Upgrade to (NCL) has delivered a decent performance in 1QFY18. Surpassing volume growth,
More informationCMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245
3QFY18 Result Update February 05, 2018 CMP* (Rs) 166 Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245 Wage Provisioning, Lower in Plant Availability Impede Earnings Growth has delivered
More informationGarware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months
2QFY217 Result Update Textile November 16, 216 Garware Wall Ropes Performance Highlights Quarterly Data (`cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq Revenue 232 214 8.5 225 3.3 EBITDA 4 26 5.9 31 29.4 Margin
More informationCMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133
4QFY17 Result Update June 06, 2017 Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133 Mixed Quarterly Performance; Volume to Remain Strong has reported a mixed performance in 4QFY17. Its blended
More informationPower Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution
2QFY19 Result Update Power Mech Projects 21 November 218 Reuters: POMP.BO; Bloomberg: POWM IN Strong Order Book Drives Robust Execution Power Mech Projects (PMPL) posted 2QFY19 consolidated revenues of
More informationRBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH
Q1FY18 RESUL UPDATE Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 RETAIL EQUITY RESEARCH RBL Bank Ltd. Banking BSE CODE: 540065 NSE CODE: RBLBANK Bloomberg CODE: RBK:IN SENSEX:
More informationCompany Overview. Financial Performance
Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 CMP: 31.25 December 24, 2015 Stock Details BSE code 523878 BSE ID TOTEX Face value ( ) 10 No of shares (m) 8.1 Market
More informationHindustan Unilever (RHS)
Jul-14 Aug-14 Oct-14 Nov-14 Dec-14 Feb-15 Mar-15 Apr-15 Jun-15 Jul-15 India Research FMCG July 22, 2015 QUARTERLY REVIEW Bloomberg: HUVR IN Reuters: HLL.BO SELL Higher A&P drove volume growth HUL s Q1FY16
More informationHOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance
RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and
More informationNet Profit 5,051 4,588 4,641 (8.1)% 1.1% 14,208 15, %
RESULTS REVIEW Share Data Market Cap Rs. 83 bn Price Rs. 202.5 BSE Sensex 15,566.10 Reuters Bloomberg Avg. Volume (52 Week) CNBK.BO CBK IN 0.1 mn 52-Week High/Low Rs. 421.45 / 198.05 Shares Outstanding
More informationNear-term pressure, but long-term outlook positive
INDUSTRY IT CMP (as on 2 Nov 2015) Rs 1,812 Target Price Rs 2,050 Nifty 8,051 Sensex 26,559 KEY STOCK DATA Bloomberg ECLX IN No. of Shares (mn) 30 MCap (Rs bn) / ($ mn) 55/843 6m avg traded value (Rs mn)
More informationKey estimate revision. Financial summary. Year FY15 121, % 16, % FY16E 137, % 20,
: price: EPS: How does our one year outlook change? We maintain rating on Aurobindo post the company s 3QFY16 results. Revenue growth for the quarter was 10% yoy: US sales of $238mn (vs. estimate of $251mn
More information